Kaerus Bioscience
Biotechnology Research • 
United Kingdom • 1-10 Employees
Company overview
| Headquarters | United Kingdom |
| Website | |
| NAICS | 541714 |
| Keywords | Autism, Epilepsy, Therapeutics, Rare Disease, Fragile X Syndrome, Orphan Disease, Neurodevelopmental Disorders, Cns Drug Development |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
Key Contact at Kaerus Bioscience
Robert H. Ring
Chief Executive Officer
Kaerus Bioscience Email Formats
Kaerus Bioscience uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@kaerusbio.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@kaerusbio.com | 100% |
About Kaerus Bioscience
Kaerus is leveraging advances in human genetics to discover and develop targeted therapeutics for rare genetic syndromes of neurodevelopment.
Kaerus Bioscience revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Kaerus Bioscience has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Kaerus Bioscience has never raised funding before.
Kaerus Bioscience Tech Stack
Discover the technologies and tools that power Kaerus Bioscience's digital infrastructure, from frameworks to analytics platforms.
Blogs
Miscellaneous
Security
JavaScript frameworks
IaaS
CDN
France
Austria
Frequently asked questions
4.8
40,000 users
